Cargando…

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds

With disease-modifying compounds targeting alpha-synuclein available in clinical trials, patient stratification according to alpha-synuclein-specific enrichment strategies is a much-needed prerequisite. Such a scenario will be exemplified for GBA, one major genetic risk factor that is specifically a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Brockmann, Kathrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545538/ https://www.ncbi.nlm.nih.gov/pubmed/33102473 http://dx.doi.org/10.3389/fcell.2020.562522

Ejemplares similares

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
por: Fouka, Maria, et al.
Publicado: (2020)

Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
por: Zoey, Fong LaiGuan, et al.
Publicado: (2021)

Intracellular Alpha-Synuclein and Immune Cell Function
por: Grozdanov, Veselin, et al.
Publicado: (2020)

Reversal of Alpha-Synuclein Fibrillization by Protein Disulfide Isomerase
por: Serrano, Albert, et al.
Publicado: (2020)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
por: Han, Tae-Un, et al.
Publicado: (2020)

Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies
por: Rcom-H'cheo-Gauthier, Alexandre N., et al.
Publicado: (2016)

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies
por: Okita, Yuho, et al.
Publicado: (2017)

Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2022)

Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
por: Oliveira da Silva, Marina I., et al.
Publicado: (2020)

Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
por: Wildburger, Norelle C., et al.
Publicado: (2020)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
por: Sandoval, Ivette M., et al.
Publicado: (2021)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus
por: Bender, Hannah, et al.
Publicado: (2021)

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62
por: Friesen, Erik L., et al.
Publicado: (2020)

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s Disease
por: Cai, Meng, et al.
Publicado: (2021)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Viral alpha-synuclein knockdown prevents spreading synucleinopathy
por: Menon, Sindhu, et al.
Publicado: (2021)

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016)

Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies
por: Kim, Jee Young, et al.
Publicado: (2019)

Comprehensive miRNome-Wide Profiling in a Neuronal Cell Model of Synucleinopathy Implies Involvement of Cell Cycle Genes
por: Findeiss, Elisabeth, et al.
Publicado: (2021)

Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
por: Schaeffer, Eva, et al.
Publicado: (2020)

Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies
por: Wu, Shenjie, et al.
Publicado: (2023)

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
por: Franco, Rafael, et al.
Publicado: (2018)

Transcriptome Analysis in a Mouse Model of Premature Aging of Dentate Gyrus: Rescue of Alpha-Synuclein Deficit by Virus-Driven Expression or by Running Restores the Defective Neurogenesis
por: Micheli, Laura, et al.
Publicado: (2021)

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

The Role of Lipids in the Initiation of α-Synuclein Misfolding
por: Kiechle, Martin, et al.
Publicado: (2020)

The Role of Glial Mitochondria in α-Synuclein Toxicity
por: Jeon, Yu-Mi, et al.
Publicado: (2020)

Editorial: Intracellular Mechanisms of α-Synuclein Processing
por: Zunke, Friederike, et al.
Publicado: (2021)

Epigenetic Priming in Immunodeficiencies
por: Martínez-Cano, Jorge, et al.
Publicado: (2019)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
por: Visanji, Naomi P., et al.
Publicado: (2019)

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
por: Poggiolini, Ilaria, et al.
Publicado: (2021)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
por: Just, Mie Kristine, et al.
Publicado: (2022)

Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
por: Drobny, Alice, et al.
Publicado: (2023)

GBA-associated PD: chances and obstacles for targeted treatment strategies
por: Höglinger, Günter, et al.
Publicado: (2022)

Activation of α7-nAChRs Promotes the Clearance of α-Synuclein and Protects Against Apoptotic Cell Death Induced by Exogenous α-Synuclein Fibrils
por: Zhao, Jifeng, et al.
Publicado: (2021)

Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model Dictyostelium discoideum
por: Mroczek, Katelyn, et al.
Publicado: (2021)

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
por: Elnageeb, Mohamed E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1408440a0a84mnkkm2bnjhcm5m